FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Barone, Amy, Chi, Dow-Chung, Theoret, Marc R., Chen, Huanyu, He, Kun, Kufrin, Dubravka, Helms, Whitney S., Subramaniam, Sriram, Zhao, Hong, Patel, Anuja, Goldberg, Kirsten B., Keegan, Patricia, PazdurLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-0898
Date:
August, 2017
File:
PDF, 556 KB
english, 2017